General Information of the Compound
Compound ID
CP0580073
Compound Name
3-[2-(4-benzhydrylpiperazin-1-yl)ethyl]-1H-benzimidazol-2-one
    Show/Hide
Structure
Formula
C26H28N4O
Molecular Weight
412.537
Canonical SMILES
O=c1[nH]c2ccccc2n1CCN1CCN(CC1)C(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C26H28N4O/c31-26-27-23-13-7-8-14-24(23)30(26)20-17-28-15-18-29(19-16-28)25(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-14,25H,15-20H2,(H,27,31)
    Show/Hide
InChIKey
IPBSBUQDPNMEBC-UHFFFAOYSA-N
Physicochemical Property
logP
3.7368
Rotatable Bonds
6
Heavy Atom Count
31
Polar Areas
44.27
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 13105525
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000186 RPMI-8226 Homo sapiens (Human)  1
1
IC50 = 950 nM
   TI
   LI
   LO
   TS